Highly rated in
Highly rated in
Check Dr. Abel D. Jarell's experience treating your condition:
About Dr. Abel D. Jarell

Abel Jarell is a Dermatologist in Dover, New Hampshire. Jarell has been practicing medicine for over 24 years and is highly rated in 7 conditions, according to our data. His top areas of expertise are Familial Atypical Multiple Mole Melanoma Syndrome, Neurocutaneous Melanosis, Giant Congenital Nevus, and Giant Congenital Melanocytic Nevus. He is licensed to treat patients in Massachusetts, Maryland, New Hampshire, and Maine. Jarell is currently accepting new patients.

His clinical research consists of co-authoring 14 peer reviewed articles and participating in 15 clinical trials in the past 15 years.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Abel D. Jarell it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Abel D. Jarell accepts the following insurance:

  •  Ambetter
  •  Anthem

Call to see if your plan is accepted.
51 Webb Pl, Dover, NH 03820
Background & Education
Graduate Institution
Harvard Medical School, 1998
Dermatology in NH
Hospital Affiliations
York Hospital
Portsmouth Regional Hospital
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

15 Clinical Trials

A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis
View 14 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors